GPhA Calls for Uniform, Achievable National System for Securing Nation’s Drug Supply Chain

Published Online: Thursday, April 25, 2013
Follow Pharmacy_Times:

WASHINGTON, DC (April 25, 2013) — At today’s House Energy and Commerce Health Subcommittee hearing entitled “Securing Our Nation's Prescription Drug Supply Chain,” Christine Simmon, GPhA’s Senior Vice President for Policy and Strategic Alliances, voiced support for a “building blocks” approach to securing the nation’s supply chain.

“We believe that every American deserves a uniform, nationwide system for monitoring and protecting the medicines they rely on,” said Simmon. To fully realize the benefits of an improved system, it is critical that we construct a path that both improves safety and provides a practical roadmap for implementation.” She continued, “The House bill includes sensible and achievable elements that will go a long way to securing the nation’s medicine supply. Making these changes is a serious and complex undertaking, and will require a thoughtful, incremental approach.”

Simmon noted that generic manufacturers supported many of the elements in discussion drafts of bills under consideration, including a major improvement in traceability for medicines. Generic manufacturers have committed to improving this process through identifying products at the unit level and to managing the data in their systems.

GPhA also welcomed the e-labeling provision included in the House version of the bill, which Simmon said would increase patient safety and provide the standard of efficient information exchange that American consumers have come to expect.

In contrast, Simmon warned the law in California is unproven and will be costly, and could pave the way for fifty separate systems that don’t work together. Creation of a uniform standard would represent a great leap forward for patients by improving the identifying information about medicines on the market today, improving the ability for law enforcement to detect counterfeiters, and making any needed recalls or returns more timely and efficient.

Related Articles
A Chicago pharmacy owner has been indicted on charges of falsely billing $2.4 million for prescription drug claims.
US Marshals have seized $1.5 million worth of unapproved prescription drugs from Stratus Pharmaceuticals at the request of the FDA and the US attorney for the Southern District of Florida.
Generic drugs are cheap, effective, and FDA approved. So, what's the problem?
The FDA is seeking comments on 28 new and 15 revised recommendations providing product-specific guidance on the design of bioequivalence studies to support Abbreviated New Drug Applications (ANDAs).
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times